Media Coverage
Filter
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Environment
- Experimental
- Healthspan
- Healthy Aging
- Infectious Disease
- Microbiome
- Pregnancy Health
- Proteomics
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Is This Microbiome Startup Selling a Wellness Fantasy?
Sean Gibbons was quoted in this Bloomberg Businessweek story examining Viome and the often questionable microbiome-wellness startup space.
T Cell Discovery Unlocks Potential for Crafting Tailored Immune Responses
This story published by Inside Precision Medicine covers ISB research showing that the different disease-fighting functions of distinct T cells are determined by the genetically encoded T-cell receptor (TCR) sequence that are unique to those cells. The findings are promising for developing custom immune responses to specific antigens.
Adding lifestyle coaching to treatment decreases cognitive decline in early Alzheimer’s
McKnights Senior Living published a news story detailing results from the ISB-led Coaching for Cognition in Alzheimer’s (COCOA) trial showing that supplementing the standard of care for early-stage Alzheimer’s disease with lifestyle coaching leads to less cognitive decline.
Computer Model Identifies Which Species Are Important in a Healthy Microbiome
ISB researchers collaborated on an international research project that found a way to determine which species in the gut are important and how they interact to create a healthy microbiome.
A systems biology perspective on the gut microbiome
ISB Associate Professor Dr. Sean Gibbons was a guest on the ISAPP Science, Microbes & Health podcast. In this episode, Gibbons talked about exploring and manipulating the complex ecology of the microbiome with the aim of engineering outputs of this system, as well as the utility of AI in microbiome science and how the microbiome will play a role in personalized medicine in the future, including in the delivery of probiotics and prebiotics.
Breakthrough Study: Alzheimer’s Patients Benefit From Lifestyle Coaching, Not Drugs
The ISB-led prospective randomized controlled trial called COCOA – Coaching for Cognition in Alzheimer’s – showed that supplementing personalized coaching along with the standard of treatment leads to less cognitive decline in early-stage Alzheimer’s patients than standard of care alone.
Long COVID: An explainer and research roundup
The Journalist’s Resource featured work by ISB researchers showing four predictive factors of long COVID. The Journalist’s Resource was created by Harvard Kennedy School’s Shorenstein Center on Media, Politics and Public Policy as an open-access online publication for journalists.
What the young can give to the old
The Economist highlights work by several ISB researchers showing that gut microbiome patterns reflect healthy aging and predict survival in humans. The work was originally published in the scientific journal Nature Metabolism.